Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
22.38 USD | +0.34% | +0.21% | +511.36% |
09/05 | Landos Biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02/04 | North American Morning Briefing : Stocks Seen -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+511.36% | 6.97Cr | |
+32.73% | 5.08TCr | |
+1.07% | 4.28TCr | |
+49.34% | 4.2TCr | |
-4.22% | 2.95TCr | |
+10.97% | 2.61TCr | |
-21.61% | 1.91TCr | |
+9.12% | 1.31TCr | |
+27.48% | 1.22TCr | |
+23.77% | 1.21TCr |
- Stock Market
- Equities
- LABP Stock
- News Landos Biopharma, Inc.
- SVB Leerink Downgrades Landos Biopharma to Market Perform from Outperform, Adjusts Price Target to $16 from $20